Evidence map›Paper›PMID 24199960›Full record

ArticleNeurobiology of aging2014

Markers of cholesterol transport are associated with amyloid deposition in the brain.

Timothy M Hughes, Oscar L Lopez, Rhobert W Evans, M Ilyas Kamboh, Jeff D Williamson, William E Klunk, Chester A Mathis, Julie C Price, Ann D Cohen, Beth E Snitz and 2 more

Abstract read
In one paragraph

Article in Neurobiology of aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The Abca7Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Role of ABCA7 in Human Health and in Alzheimer's Disease.International journal of molecular sciences · 2021
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Protective Variants in Alzheimer's Disease.Current genetic medicine reports · 2019
    Article
  18. Article
  19. Article
  20. Apolipoproteins and Alzheimer's pathophysiology.Alzheimer's & dementia (Amsterdam, Netherlands) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Timothy M HughesDepartment of Internal Medicine, School of Medicine, Wake Forest University, Winston-Salem, NC, USA. Electronic address: tmhughes@wakehealth.edu.
Oscar L LopezDepartment of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Rhobert W EvansDepartment of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
M Ilyas KambohDepartment of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Jeff D WilliamsonDepartment of Internal Medicine, School of Medicine, Wake Forest University, Winston-Salem, NC, USA.
William E KlunkDepartment of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Chester A MathisDepartment of Radiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Julie C PriceDepartment of Radiology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Ann D CohenDepartment of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Beth E SnitzDepartment of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Steven T DekoskyUniversity of Virginia School of Medicine, University of Virginia, Charlottesville, VA, USA.
Lewis H KullerDepartment of Internal Medicine, School of Medicine, Wake Forest University, Winston-Salem, NC, USA.
University of Pittsburgh · USWake Forest University · USUniversity of Virginia · US

Funding

Vascular Moderators of the Impact of Alzheimer's Pathology in the Young-OldP01AG025204 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN, Ann D. Cohen · 2005 to 2026
$56.5M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMBOH, M. ILYAS · 1985 to 2019
$43.0M
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD PathophysiologyRF1AG025516 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AIZENSTEIN, HOWARD J, VILLEMAGNE, VICTOR LUIS · 2014 to 2021
$9.0M
Search for the Alzheimers GenesR01AG030653 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMBOH, M. ILYAS · 2009 to 2019
$7.7M
TRAINING IN THE EPIDEMIOLOGY OF AGINGT32AG000181 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STROTMEYER, ELSA S. · 1989 to 2025
$6.2M
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD PathophysiologyR01AG025516 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HOWARD J AIZENSTEIN, Victor Luis Villemagne · 2024 to 2026
$4.4M
AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLYR37AG025516 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLUNK, WILLIAM E · 2005 to 2014
$4.3M
Translational Training in Aging and Alzheimer’s Disease Related DisordersT32AG033534 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI STEPHEN B. KRITCHEVSKY · 2009 to 2026
$3.6M
Deep Resequencing of Candidate Gene Regions in Late-onset Alzheimer's DiseaseR01AG041718 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMBOH, M. ILYAS · 2012 to 2016
$3.0M
Subjective Cognitive Complants, Cognitive Decline and B-Amyloid Deposition in NonK23AG038479 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SNITZ, BETH · 2010 to 2014
$577k
NIA NIH HHS AG030653NIA NIH HHS AG041718NIA NIH HHS K23 AG038479NIA NIH HHS P01 AG025204NIA NIH HHS P50 AG005133NIA NIH HHS R01 AG030653NIA NIH HHS R01 AG041718NIA NIH HHS R37 AG025516NIA NIH HHS RF1 AG025516NIA NIH HHS T32 AG000181NIA NIH HHS T32 AG033534
6 · The paper itself

Abstract

Cholesterol is implicated in the development of late-onset Alzheimer's disease (AD). We sought to determine the associations between beta amyloid (Aβ) plaque deposition in vivo using Pittsburgh compound B (PiB) and several indices of cholesterol homeostasis (i.e., total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, apolipoprotein E (ApoE), clusterin, oxysterol metabolites of cholesterol, and previously reported genes associated with late-onset AD) in 175 nondemented elderly subjects. High Aβ deposition was associated significantly with a lower Mini-Mental State Examination score (<27 points, p = 0.04), high systolic blood pressure (p = 0.04), carrying the apolipoprotein E epsilon 4 allele (p < 0.01), and lower plasma ApoE levels (p = 0.02), and variation in the ABCA7 (p = 0.02) and EPHA1 genes (p = 0.02). Cholesterol measures were not related to Aβ deposition in this cohort of nondemented elderly adults. However, plasma and genetic factors relating to cholesterol transport were associated with Aβ deposition in the brain. A better understanding of cholesterol transport mechanisms may lead to the design of potential targets for the prevention of Aβ deposition in the brain.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesApolipoprotein E4ATP-Binding Cassette TransportersBiological TransportBrainCholesterolCohort StudiesFemaleHomeostasisHumansMaleMolecular Targeted TherapyPlaque, AmyloidABCA7 protein, humanAmyloid beta-PeptidesApolipoprotein E4ATP-Binding Cassette TransportersCholesterolReceptor, EphA1Alzheimer's diseaseCholesterolGenesImagingLipidsMild cognitive impairmentOldest old

Identifiers

PMID24199960
PMCPMC3896052
OpenAlexW2008298240

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.